Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellectar Biosciences

0.2642
+0.01265.01%
Post-market: 0.2624-0.0018-0.68%18:13 EDT
Volume:360.53K
Turnover:94.14K
Market Cap:12.17M
PE:-0.19
High:0.2676
Open:0.2580
Low:0.2538
Close:0.2516
Loading ...
Aug 11, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2020

Major Issues Report

8-K - Current report
Aug 04, 2020

Major Issues Report

8-K - Current report
Jul 21, 2020

Major Issues Report

8-K - Current report
Jul 13, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jul 01, 2020

Major Issues Report

8-K - Current report
Jun 25, 2020

Major Issues Report

8-K - Current report
Jun 12, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 12, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 11, 2020

Major Issues Report

8-K - Current report
Jun 10, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 05, 2020

Major Issues Report

8-K - Current report
Jun 03, 2020

Major Issues Report

8-K - Current report
Jun 01, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 01, 2020

Major Issues Report

8-K - Current report
May 26, 2020

Major Issues Report

8-K - Current report
May 20, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 20, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933